Thomas C Wetter Selected Research

Thomas C Wetter Research Topics

7	Restless Legs Syndrome (Restless Legs) 03/2010 - 01/2002
4	Sleep Initiation and Maintenance Disorders (Insomnia) 01/2022 - 03/2010
4	Sleep Wake Disorders 01/2022 - 09/2006
4	Narcolepsy 05/2012 - 07/2002
3	Parkinson Disease (Parkinson's Disease) 05/2012 - 09/2002
2	Sleepiness 01/2017 - 03/2016
1	Wounds and Injuries (Trauma) 01/2022
1	Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder) 01/2022
1	Major Depressive Disorder (Major Depressive Disorders) 01/2020
1	Inflammation (Inflammations) 01/2020
1	Fatigue 01/2017
1	Sleep Deprivation 03/2016
1	Irritable Bowel Syndrome (Syndrome, Irritable Bowel) 07/2015
1	Obsessive-Compulsive Disorder (Disorder, Obsessive-Compulsive) 07/2015
1	Disorders of Excessive Somnolence (Hypersomnia) 05/2012
1	Fibromyalgia (Fibrositis) 05/2012
1	Obesity 02/2012
1	Insulin Resistance 02/2012
1	Mood Disorders (Mood Disorder) 09/2011
1	Apnea 03/2010
1	Obstructive Sleep Apnea 03/2010
1	Dystonia (Limb Dystonia) 07/2008
1	Tardive Dyskinesia 07/2008
1	Dystonic Disorders (Writer's Cramp) 07/2008
1	Body Weight (Weight, Body) 07/2002

3	Levodopa (L Dopa)FDA LinkGeneric 04/2008 - 10/2003
3	Dopamine (Intropin)FDA LinkGeneric 04/2008 - 01/2002
3	Dopamine Agonists (Dopamine Agonist)IBA 04/2008 - 08/2005
2	Pharmaceutical PreparationsIBA 01/2022 - 05/2009
2	CytokinesIBA 01/2020 - 09/2006
2	Glucose (Dextrose)FDA LinkGeneric 02/2012 - 03/2010
2	Opioid Analgesics (Opioids)IBA 04/2008 - 08/2005
1	LigandsIBA 01/2020
1	Interleukin-6 (Interleukin 6)IBA 01/2020
1	CC ChemokinesIBA 01/2020
1	Hypnotics and Sedatives (Sedatives)IBA 01/2019
1	Wakefulness-Promoting AgentsIBA 01/2017
1	Indicators and Reagents (Reagents)IBA 03/2016
1	gamma-Aminobutyric Acid (GABA)IBA 05/2012
1	Hormones (Hormone)IBA 09/2011
1	Corticotropin-Releasing HormoneIBA 09/2011
1	Dexamethasone (Maxidex)FDA LinkGeneric 09/2011
1	Antipsychotic Agents (Antipsychotics)IBA 07/2008
1	Botulinum Toxins (Botulinum Toxin)IBA 07/2008
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 09/2006
1	Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA 09/2006
1	BenzodiazepinesIBA 08/2005
1	BenserazideIBA 10/2003
1	Cabergoline FDA LinkGeneric 10/2003
1	Dopamine Agents (Dopaminergic Agents)IBA 09/2002
1	OrexinsIBA 07/2002
1	HLA-DR2 Antigen (HLA DR2 Antigen)IBA 07/2002
1	Pergolide (Permax)FDA Link 01/2002